Skip to main content
Erschienen in: World Journal of Surgery 7/2012

01.07.2012

Effects of Post-transplant Enteral Nutrition with an Immunomodulating Diet Containing Hydrolyzed Whey Peptide after Liver Transplantation

verfasst von: Toshimi Kaido, Yasuhiro Ogura, Kohei Ogawa, Koichiro Hata, Atsushi Yoshizawa, Shintaro Yagi, Shinji Uemoto

Erschienen in: World Journal of Surgery | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Complications due to infections, including bacteremia, often arise after liver transplantation (LT) and are the most frequent causes of in-hospital death. Hydrolyzed whey peptide (HWP), a protein complex derived from milk, has anti-inflammatory effects. The present study retrospectively analyzes the effects of early enteral nutrition with a new immunomodulating diet (IMD) enriched with HWP in patients after living-donor LT (LDLT).

Methods

Data from 76 consecutive adult patients who underwent LDLT at our institute between September 2009 and March 2011 were retrospectively analyzed. The new IMD enriched with HWP and a conventional elemental diet were administered enterally to 40 (HWP group) and 36 (control group) patients, respectively, within the first 24 h after surgery.

Results

The characteristics of patients and surgical parameters did not differ between the two groups. The incidence of bacteremia was significantly lower in the HWP (15%) than in the control group (47%) (p = 0.002). The in-hospital mortality due to infection was a little lower in the HWP group than in the control group, although there was no statistical difference (p = 0.145). The fasting blood glucose level at postoperative day 7 was significantly lower in the HWP group than in the control group (p = 0.005). The incidence of acute cellular rejection was similar between the two groups (p = 0.858).

Conclusion

Early enteral nutrition with the new IMD enriched with HWP can prevent post-transplant bacteremia and post-transplant hyperglycemia without increasing the incidence of acute cellular rejection.
Literatur
1.
2.
Zurück zum Zitat Pikul J, Sharpe MD, Lowndes R et al (1994) Degree of preoperative malnutrition is predictive of postoperative morbidity in liver transplant recipients. Transplantation 57:469–472PubMedCrossRef Pikul J, Sharpe MD, Lowndes R et al (1994) Degree of preoperative malnutrition is predictive of postoperative morbidity in liver transplant recipients. Transplantation 57:469–472PubMedCrossRef
3.
Zurück zum Zitat Selberg O, Böttcher J, Tusch G et al (1997) Identification of high-and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25:625–657CrossRef Selberg O, Böttcher J, Tusch G et al (1997) Identification of high-and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 25:625–657CrossRef
4.
Zurück zum Zitat Sanchez AJ, Aranda-Michel J (2006) Nutrition for the liver transplant patient. Liver Transpl 12:1310–1316PubMedCrossRef Sanchez AJ, Aranda-Michel J (2006) Nutrition for the liver transplant patient. Liver Transpl 12:1310–1316PubMedCrossRef
5.
Zurück zum Zitat Stickel F, Inderbitzin D, Candinas D (2008) Role of nutrition in liver transplantation for end-stage chronic liver disease. Nutr Rev 66:47–54PubMedCrossRef Stickel F, Inderbitzin D, Candinas D (2008) Role of nutrition in liver transplantation for end-stage chronic liver disease. Nutr Rev 66:47–54PubMedCrossRef
6.
Zurück zum Zitat Kaido T, Egawa H, Tsuji H et al (2009) In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl 15:1420–1425PubMedCrossRef Kaido T, Egawa H, Tsuji H et al (2009) In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl 15:1420–1425PubMedCrossRef
7.
Zurück zum Zitat Weimann A, Braga M, Harsanyi L et al (2006) ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25:224–244PubMedCrossRef Weimann A, Braga M, Harsanyi L et al (2006) ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25:224–244PubMedCrossRef
8.
Zurück zum Zitat Kaido T, Mori A, Ogura Y et al (2010) Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation. Hepatogastroenterology 57:1522–1525PubMed Kaido T, Mori A, Ogura Y et al (2010) Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation. Hepatogastroenterology 57:1522–1525PubMed
9.
Zurück zum Zitat Marshall K (2004) Therapeutic applications of whey protein. Altern Med Rev 9:136–156PubMed Marshall K (2004) Therapeutic applications of whey protein. Altern Med Rev 9:136–156PubMed
10.
Zurück zum Zitat Inomata Y, Uemoto S, Asonuma K et al (2000) Right lobe graft in living donor liver transplantation. Transplantation 69:258–264PubMedCrossRef Inomata Y, Uemoto S, Asonuma K et al (2000) Right lobe graft in living donor liver transplantation. Transplantation 69:258–264PubMedCrossRef
11.
Zurück zum Zitat Ito T, Kiuchi T, Egawa H et al (2003) Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 76:158–163PubMedCrossRef Ito T, Kiuchi T, Egawa H et al (2003) Surgery-related morbidity in living donors of right-lobe liver graft: lessons from the first 200 cases. Transplantation 76:158–163PubMedCrossRef
12.
Zurück zum Zitat Morioka D, Egawa H, Kasahara M et al (2007) Outcomes of adult-to-adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg 245:315–325PubMedCrossRef Morioka D, Egawa H, Kasahara M et al (2007) Outcomes of adult-to-adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg 245:315–325PubMedCrossRef
13.
Zurück zum Zitat Inomata Y, Tanaka K, Egawa H et al (1996) The evolution of immunosuppression with FK 506 in pediatric living related liver transplantation. Transplantation 61:247–252PubMedCrossRef Inomata Y, Tanaka K, Egawa H et al (1996) The evolution of immunosuppression with FK 506 in pediatric living related liver transplantation. Transplantation 61:247–252PubMedCrossRef
14.
Zurück zum Zitat Egawa H, Ohdan H, Haga H et al (2008) Current status of liver transplantation across ABO blood-type barrier. J Hepatobiliary Pancreat Surg 15:131–138PubMedCrossRef Egawa H, Ohdan H, Haga H et al (2008) Current status of liver transplantation across ABO blood-type barrier. J Hepatobiliary Pancreat Surg 15:131–138PubMedCrossRef
15.
Zurück zum Zitat Egawa H, Teramukai S, Haga H et al (2008) Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 47:143–152PubMedCrossRef Egawa H, Teramukai S, Haga H et al (2008) Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 47:143–152PubMedCrossRef
16.
Zurück zum Zitat Garner J, Jarvis W, Emori T et al (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128–140PubMedCrossRef Garner J, Jarvis W, Emori T et al (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128–140PubMedCrossRef
17.
Zurück zum Zitat Plank LD, McCall JL, Gane EJ et al (2005) Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy. Clin Nutr 24:288–296PubMedCrossRef Plank LD, McCall JL, Gane EJ et al (2005) Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy. Clin Nutr 24:288–296PubMedCrossRef
18.
Zurück zum Zitat Kume H, Okazaki K, Sasaki H (2006) Hepatoprotective effects of whey protein on d-galactosamine-induced hepatitis and liver fibrosis in rats. Biosci Biotechnol Biochem 70:1281–1285PubMedCrossRef Kume H, Okazaki K, Sasaki H (2006) Hepatoprotective effects of whey protein on d-galactosamine-induced hepatitis and liver fibrosis in rats. Biosci Biotechnol Biochem 70:1281–1285PubMedCrossRef
19.
Zurück zum Zitat Park C, Hsu C, Neelakanta G et al (2009) Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation 7:1031–1036CrossRef Park C, Hsu C, Neelakanta G et al (2009) Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation 7:1031–1036CrossRef
Metadaten
Titel
Effects of Post-transplant Enteral Nutrition with an Immunomodulating Diet Containing Hydrolyzed Whey Peptide after Liver Transplantation
verfasst von
Toshimi Kaido
Yasuhiro Ogura
Kohei Ogawa
Koichiro Hata
Atsushi Yoshizawa
Shintaro Yagi
Shinji Uemoto
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-012-1529-9

Weitere Artikel der Ausgabe 7/2012

World Journal of Surgery 7/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.